Federal Trade Commission Unleashes Investigation into Drug Shortages
The U.S. healthcare system has been grappling with a critical issue in recent years - the shortage of generic drugs. This shortage has had a significant impact on patients, hospitals, and healthcare providers across the country, leading to rationing of crucial medicines and posing risks to patient safety. In response to this pressing concern, the Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) have launched an investigation to delve into the root causes and potential solutions for these generic drug shortages.
Over the past year, the United States has experienced an unprecedented shortfall of generic drugs, ranging from injectable cancer therapies to essential pain treatments. These shortages have forced hospitals to ration drugs, making it increasin...